ResMed (RMD +10.2%), a maker of equipment for treating respiratory disorders, is surging...
Friday, January 27, 2012, 1:41 PM ETResMed (RMD +10.2%), a maker of equipment for treating respiratory disorders, is surging following its FQ2 beat. Likely helping matters is an upgrade to Buy from Deutsche, which thinks the rebound seen in ResMed's U.S. equipment sales (Americas revenue rose 12% Y/Y) suggests the company can keep growing earnings at a double-digit annual clip. (transcript)
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles